Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F5UZA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,365
Award facts
- Contract value 100% obligated
- $40,365.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $40,365.01 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on November 13, 2025, with an ultimate completion date of November 14, 2025. This firm fixed-price, non-set-aside contract was awarded competitively and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania.
This award exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. As a major healthcare solutions provider, the company maintains a comprehensive $999,999,999.00 IDC through December 2026 that enables it to supply a broad spectrum of pharmaceutical products and medical supplies globally. RINVOQ (upadacitinib) is a Janus kinase inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, reflecting the Defense Health Agency's need for specialty medications to support military personnel and beneficiaries. AmerisourceBergen's consistent receipt of competitively awarded federal contracts underscores its capability to meet rigorous procurement standards across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F5UZA?
SPE2DR26F5UZA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F5UZA worth?
The government has obligated $40,365 on SPE2DR26F5UZA.
Is contract SPE2DR26F5UZA an order under another contract?
Yes. SPE2DR26F5UZA is a delivery order under SPE2DR25D2105, an indefinite delivery contract.
Was contract SPE2DR26F5UZA competed?
The extent of competition for SPE2DR26F5UZA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award